Ipsen agrees to buy Kartos Therapeutics in deal worth up to $1.75 billion

The French drugmaker will pay $450 million upfront, with another $1.3 billion tied to regulatory and sales milestones as it seeks to bolster its cancer-medicine pipeline.

28d ago